Open Journal of Internal Medicine

Volume 6, Issue 3 (September 2016)

ISSN Print: 2162-5972   ISSN Online: 2162-5980

Google-based Impact Factor: 0.49  Citations  

Graves’ Disease in Senegal: Clinical and Evolutionary Aspects

HTML  XML Download Download as PDF (Size: 425KB)  PP. 77-82  
DOI: 10.4236/ojim.2016.63013    1,867 Downloads   2,980 Views  Citations

ABSTRACT

Objectives: To assess the clinical particularities and management of Graves’ disease at the Medical Clinic II of the Abass Ndao Hospital Centre in Dakar. Patients and methods: This was a retrospective, descriptive study on records of patients monitored for Graves' disease from 1 January 2010 to 31 December 2014 (5 years). Socio-demographic, clinical treatment and changing parameters were evaluated. Outcomes: 878 patients were included and among them 542 had been monitored for at least 18 months. The sex ratio (M/F) was 0.2 and the average age was 34.8 ± 12 years. The average consultation period was 10.7 ± 2 months. Free T4 at diagnosis was > 80 pmol/l (36.6%). Prolonged medical treatment was reported in 96.7% of patients. The average dose for initial therapy with Carbimazole was 37 ± 9 mg/day. Beta-blockers were used in 64% and anxiolytics in 40.5% of cases. The average period for administering the maintenance dose was 5.6 months. Patients’ attendance and compliance stood at 17.7% and 53.1% respectively. Complications, mainly cardiothyreosis, were found in 13% of cases. Goitre regression was found in 13.9% of cases and that of exophthalmos stood at 19.5%. Among our patients, 38.2% were lost to follow-up. The remission rate was 36.5% and thyroidectomy involved 14.5% of patients. Only stage of goiter (p = 0.007) and initial free T4 value (p = 0.003) were statistically associated with remission. Conclusion: Graves’ disease management raises follow-up problems. Indeed, the medical treatment is long while the number of patients lost to follow-up is high. As the only radical alternative available is surgery, it is therefore essential to promote the development of radioactive iodine therapy to expand the therapeutic choice.

Share and Cite:

Sarr, A. , Diédhiou, D. , Ndour-Mbaye, N. , Sow, D. , Diallo, I. , Alaoui, S. , Diouf, M. and Diop, S. (2016) Graves’ Disease in Senegal: Clinical and Evolutionary Aspects. Open Journal of Internal Medicine, 6, 77-82. doi: 10.4236/ojim.2016.63013.

Cited by

[1] Thyrotoxicosis in Africa: a systematic review and meta-analysis of the clinical presentation
The Egyptian Journal of …, 2022
[2] Graves' Disease in 100 Cases in Conakry: Epidemiological, Clinical, Therapeutic, and Evolutionary Aspects
Open Journal of …, 2022
[3] Les facteurs associés à la rémission au cours du suivi de la maladie de Basedow
Revue Africaine de …, 2022
[4] Multidisciplinary thyroid disease management in The Gambia: Results of a 6-year multinational collaboration
East and Central …, 2021
[5] Pathologie thyroïdienne au Centre Hospitalier Universitaire de Conakry en Guinée
2020
[6] Hyperthyroidism in a Private Medical Services Center, Addis Ababa: A 5-Year Experience
2020
[7] Evolution of Graves's Disease: Impact of Socio-Demographic and Clinical Factors in Senegalese Subject
2020
[8] Atteintes auto-immunes au cours de la pathologie thyroïdienne à Conakry
2019
[9] Thyroid Disease at the University Hospital of Conakry, Guinea
2019
[10] Graves' Disease in Men's Subjects
2018

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.